PERSPECTA

News from every angle

← Back to headlines

Novo Nordisk's Wegovy Weight-Loss Pill Approved for Sale in EU

Novo Nordisk's Wegovy weight-loss pill has received approval for sale in the European Union, including a higher-dose version in a single-dose pen. This approval marks a significant milestone for the company and its obesity treatment.

15 Jul, 16:53 — 15 Jul, 16:53
PostShare

Sources

Showing 1 of 4 sources
seeking-alphaMixed24d ago

Novo wins EU nod for Wegovy pill and higher-dose Wegovy in single-dose pen

Read full article →

Coverage Timeline

First report: seeking-alpha · 15 Jul, 16:53Full coverage: 4 · 55mWindow: 55m
Left-leaningCenterRight-leaning
seeking-alpha15 Jul, 16:53First to report

Novo wins EU nod for Wegovy pill and higher-dose Wegovy in single-dose pen

dr-dk15 Jul, 17:12

Novo Nordisk får grønt lys til vægttabspille i EU

berlingske15 Jul, 17:47

Novos Wegovy-pille er godkendt til salg i EU

politiken15 Jul, 17:48Latest update

»Mere end en milepæl«, jubler direktøren: Nu er Novos Wegovy-pille godkendt til salg i EU

Related Stories

Stock Funds Decline in July Amid AI Volatility

27m ago

Multiple Companies Release Latest Quarterly Earnings Reports

32m ago

MTN Nigeria Confirms 25GB Data Reward, Warns Against Fake Links

33m ago

Renovated Apartment for Sale in Starigrad Paklenica with Sea View

36m ago